Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Cardio Diagnostics Holdings Inc

CDIO ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$1.98

▼ -4.35%

Market Cap $5.86M · Vol 4.67K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$5.86M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

35.44

Momentum

Beta

2.17

vs Market

52W High

$7.91

74.97% below

52W Low

$1.01

96.04% above

Volume

4.67K

Avg 6.92K

P/B

0.71

Price-to-book

ROE

N/A

Return on equity

Free Float

91.69%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Cardio Diagnostics Holdings Inc (CDIO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CDIO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+7.61%

+15.79%

+2.59%

-60.32%

YTD

-26.94%

-47.76%

-84.29%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$14.83K
Net Income	$-6,498,170.00
Revenue Growth (YoY)	-28.29%
Gross Margin	100.00%
Operating Margin	-43,737.46%
Net Profit Margin	-43,832.49%
ROE	N/A
ROA · ROIC	-70.70% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	320.16
P/B	0.71
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	2.96M

Technical Indicators

50-Day SMA	$1.83
200-Day SMA	$2.27
RSI (14)	35.44
Beta	2.17
52-Week High	$7.91
52-Week Low	$1.01

Volume Today	4.67K
Avg Daily Volume (30D)	6.92K
Relative Volume	0.67x
Volatility (10D)	48.22
Volatility (30D)	83.78
Free Float	91.69%

Analyst Consensus

N/A

Current Price $1.98

Mean Target N/A

52W Low$1.01 52W High$7.91

Current

Target

$1.01 $7.91

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG013P0VV74

ISINUS14159C2026

CountryUSA

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co., Ltd. -1.14% ARGX.BR argenx SE -1.09% ARGX argenx SE -1.82% INSM Insmed Incorporated -1.18% 2269.HK WuXi Biologics (Cayman) Inc. -2.74%

Company Profile

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.